Table 1 (abstract P016). Mean annual hospital-associated costs of JIA (and 95% CIs) per patient during clinically inactive disease on bDMARDs (pre-withdrawal) and during the first year following withdrawal of bDMARDs (post-withdrawal, subdivided into discontinuing and tapering)
From: Proceedings of the 28th European Paediatric Rheumatology Congress (PReS 2022)
Group and period | Total (n=55) pre-withdrawal | Total (n=55) post-withdrawal | Discontinuation (n=25) pre- withdrawal | Discontinuation (n=25) post-withdrawal | Taper (n=30) pre-withdrawal | Taper (n=30) post-withdrawal |
|---|---|---|---|---|---|---|
Total | €9,906 (€8,983 - €10,845) | €5,633 (€4,711 - €6,568) | €9,670 (€8078 - €11,270) | €4,338 (€3,225 - €5,426) | €10,103 (€9,032 - €11,185) | €6,712 (€5,386 - €8,058) |
Medication | €7,940 (€7,041 - €8,840) | €3,381 (€2,682 - €4,070) | €7,537 (€5,857 - €9,217) | €2,128 (€1,246 - €2,999) | €8,275 (€7,453 - €9,090) | €4,426 (€3,560 - €5,296) |
Consultation | €1,429 (€1,309 - €1,549) | €1,585 (€1,389 - €1,778) | €1,671 (€1,502 - €1,840) | €1,674 (€1,414 - €1,932) | €1,227 (€1,100 - €1,355) | €1,511 (€1,236 - €1,785) |
Diagnostics* | €294 (€201 - €386) | €300 (€212 - €388) | €366 (€187 - €542) | €358 (€203 - €513) | €234 (€157 - €311) | €253 (€158 - €347) |
Other** | €244 (€0 - €637) | €367 (€0 - €786) | €96 (€0 - €199) | €179 (€6 - €3,501) | €367 (€0 - €1,074) | €523 (€0 - €1,274) |